NASHVILLE, Tenn. — A fully automated artificial intelligence approach predicted post-nephrectomy glomerular filtration rate with comparable accuracy as validated clinical prediction models, according ...
Five-year survival rates following nephrectomy for renal cell carcinoma are higher among patients with favorable vs unfavorable histology. Survival rates at 5 years following partial or radical ...
ATLANTA—The rate of perioperative blood transfusion after nephrectomy appears to be higher in general practice than the rates commonly cited in published urologic reports, researchers reported at the ...
There are multiple potential applications for circulating tumor (ct)DNA in kidney cancer. The post-nephrectomy remission, adjuvant therapy decision, and monitoring for response or progression on ...
A randomized phase II trial of pazopanib (PAZ) vs. temsirolimus (TEM) in patients (pts) with advanced clear-cell renal cell carcinoma (accRCC) with intermediate or poor-risk disease (the TemPa trial).
Current guidelines recommend up to 5 years of follow-up assessment for patients with localized renal cell carcinoma treated by nephrectomy; however, the recommendations are supported only by low-level ...
The double-blind, multicenter, randomized KEYNOTE-564 study (NCT03142334) is the first positive phase 3 study of adjuvant immunotherapy for patients with renal cell carcinoma (RCC) at ...
First preliminary results of artificial intelligence-generated, explainable treatment recommendations for renal cell cancer based on multidisciplinary cancer conferences. Multivariate adjusted ...
Kidney removal surgery, a nephrectomy, can cause pain. While most discomfort fades in weeks, some patients experience chronic pain. Understanding different pain types like flank, back, and nerve pain ...
Cardiac transplant status is not significantly associated with adverse in-hospital outcomes in patients with kidney cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results